Nurix Therapeutics (NRIX) Reports First Clinical Evidence of CNS Activity of NX-5948

Go back to Nurix Therapeutics (NRIX) Reports First Clinical Evidence of CNS Activity of NX-5948
(NASDAQ: NRIX) Delayed: 18.95 +0.30 (1.61%)
Previous Close $18.65    52 Week High
Open $18.49    52 Week Low
Day High $19.08    P/E N/A 
Day Low $18.39    EPS
Volume 294,016